Mark Brosius, EVP and Chief Manufacturing and Supply Chain officer of Intuitive Surgical Inc, filed a Form 4 on November 20, 2026, disclosing two open-market sales of common stock on November 19 and November 20, 2026, executed under a Rule 10b5-1 trading plan.
Key Highlights
- First sale: 46 shares of common stock disposed of on November 19, 2026, at a price of $420.95 per share.
- Second sale: 46 shares of common stock disposed of on November 20, 2026, at a price of $407.24 per share.
- Remaining holdings: Brosius directly held 227 shares of common stock following the November 20 transaction, down from 273 after the November 19 transaction.
- Trading plan: Both transactions were made pursuant to a Rule 10b5-1 trading plan that the filing states expires on February 14, 2027.
- Reporting person role: Mark Brosius is identified in the filing as an officer with the title EVP and Chief Manufacturing and Supply Chain officer.
- Issuer: The issuer is listed as Intuitive Surgical Inc, trading on NASDAQ:ISRG.
Brosius Discloses Two-Day Share Sale Under 10b5-1 Plan
According to the Form 4 filed with the SEC on November 20, 2026, Mark Brosius disposed of a total of 92 shares of Intuitive Surgical Inc common stock across two consecutive trading days. The filing identifies Brosius as an officer of the company, holding the title of EVP and Chief Manufacturing and Supply Chain officer, and indicates that all transactions were direct holdings.
The first transaction, dated November 19, 2026, involved the sale of 46 shares at $420.95 per share, leaving Brosius with a reported direct beneficial ownership of 273 shares. The second transaction, dated November 20, 2026, involved the sale of an additional 46 shares at $407.24 per share, reducing his directly held position to 227 shares, as reported in the filing.
The filing notes that both transactions were carried out "in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027." The form was signed on November 20, 2026, by Stephanie Lim-Ignacio on behalf of Mark Brosius. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
Mark Brosius, an executive officer at Intuitive Surgical Inc (NASDAQ:ISRG), reported the sale of 92 total shares of common stock on November 19 and 20, 2026, at prices of $420.95 and $407.24 respectively, under a Rule 10b5-1 plan expiring February 14, 2027. His remaining direct ownership stands at 227 shares.





Please wait processing your request...